BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16261411)

  • 1. A cost-effectiveness analysis of two rehabilitation support services for women with breast cancer.
    Gordon LG; Scuffham P; Battistutta D; Graves N; Tweeddale M; Newman B
    Breast Cancer Res Treat; 2005 Nov; 94(2):123-33. PubMed ID: 16261411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of rehabilitation support services on health-related quality of life for women with breast cancer.
    Gordon LG; Battistutta D; Scuffham P; Tweeddale M; Newman B
    Breast Cancer Res Treat; 2005 Oct; 93(3):217-26. PubMed ID: 16136270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis.
    van den Hout WB; de Jong Z; Munneke M; Hazes JM; Breedveld FC; Vliet Vlieland TP
    Arthritis Rheum; 2005 Feb; 53(1):39-47. PubMed ID: 15696568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of three physiotherapy treatments for non-specific neck disorders alongside a randomized trial.
    Lewis M; James M; Stokes E; Hill J; Sim J; Hay E; Dziedzic K
    Rheumatology (Oxford); 2007 Nov; 46(11):1701-8. PubMed ID: 17956916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brief pain management program compared with physical therapy for low back pain: results from an economic analysis alongside a randomized clinical trial.
    Whitehurst DG; Lewis M; Yao GL; Bryan S; Raftery JP; Mullis R; Hay EM
    Arthritis Rheum; 2007 Apr; 57(3):466-73. PubMed ID: 17394176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of community-based physical activity interventions.
    Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
    Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation.
    Haines TP; Sinnamon P; Wetzig NG; Lehman M; Walpole E; Pratt T; Smith A
    Breast Cancer Res Treat; 2010 Nov; 124(1):163-75. PubMed ID: 20734132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of advanced nursing care on quality of life and cost outcomes of women diagnosed with breast cancer.
    Ritz LJ; Nissen MJ; Swenson KK; Farrell JB; Sperduto PW; Sladek ML; Lally RM; Schroeder LM
    Oncol Nurs Forum; 2000 Jul; 27(6):923-32. PubMed ID: 10920832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of intensive exercise therapy directly following hospital discharge in patients with arthritis: results of a randomized controlled clinical trial.
    Bulthuis Y; Mohammad S; Braakman-Jansen LM; Drossaers-Bakker KW; van de Laar MA
    Arthritis Rheum; 2008 Feb; 59(2):247-54. PubMed ID: 18240191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What determines the health-related quality of life among regional and rural breast cancer survivors?
    DiSipio T; Hayes S; Newman B; Janda M
    Aust N Z J Public Health; 2009 Dec; 33(6):534-9. PubMed ID: 20078570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of a community based exercise programme in over 65 year olds: cluster randomised trial.
    Munro JF; Nicholl JP; Brazier JE; Davey R; Cochrane T
    J Epidemiol Community Health; 2004 Dec; 58(12):1004-10. PubMed ID: 15547060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive home visits to older people are cost-effective.
    Sahlen KG; Löfgren C; Mari Hellner B; Lindholm L
    Scand J Public Health; 2008 May; 36(3):265-71. PubMed ID: 18519295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective.
    Delea TE; El-Ouagari K; Karnon J; Sofrygin O
    Breast Cancer Res Treat; 2008 Apr; 108(3):375-87. PubMed ID: 17653859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of sevelamer in patients with end-stage renal disease.
    Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
    Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of two physiotherapy interventions for primary care back and neck pain patients: cost effectiveness analysis.
    Manca A; Dumville JC; Torgerson DJ; Klaber Moffett JA; Mooney MP; Jackson DA; Eaton S
    Rheumatology (Oxford); 2007 Sep; 46(9):1495-501. PubMed ID: 17711873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
    Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
    Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.